Ferrous%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252520ascorbate

# Ferrous ascorbate ## Overview Ferrous ascorbate is an oral **ferrous (Fe²⁺) iron salt combined with ascorbate (vitamin C)**. It is used to replace iron in iron-deficiency states. - Dose must be calculated as **elemental iron**, not the total ferrous ascorbate salt. - Elemental iron content varies by product; verify the package or local formulary. Do **not** assume that “100 mg ferrous ascorbate” equals 100 mg elemental iron. - Vitamin C may improve absorption, but additional vitamin C is usually unnecessary. - Use only after iron deficiency is reasonably established or strongly suspected; iron can worsen some non–iron-deficiency anemias and iron-overload disorders. ## Primary Indications - Treatment of iron-deficiency anemia. - Treatment of iron deficiency without anemia when clinically indicated. - Prevention of iron deficiency in selected high-risk patients, including pregnancy or inadequate dietary intake. - Increased iron requirements, such as during pregnancy, lactation, or recovery from blood loss. ## Adult Dosing Doses below refer to **elemental iron**: - **Iron-deficiency anemia:** **100–200 mg elemental iron/day** orally, usually once daily or in divided doses. Many patients tolerate and absorb **40–65 mg once daily or on alternate days** better than multiple daily doses. - **Iron deficiency without anemia or prophylaxis:** Commonly **30–60 mg elemental iron/day**; local protocols may differ. - Continue treatment for approximately **3 months after hemoglobin normalizes** to replenish iron stores, guided by ferritin and clinical response. - There is no universally established ferrous-ascorbate-specific maximum. In routine oral therapy, **200 mg elemental iron/day** is a commonly used upper treatment dose; higher doses should be specialist- or protocol-directed because adverse effects increase and absorption does not necessarily improve. Administration: - Take on an empty stomach if tolerated. - If gastrointestinal effects occur, take with a small amount of food; absorption may be reduced. - Avoid taking with milk, calcium, tea, coffee, antacids, or high-fiber foods. - Swallow tablets whole unless the product is specifically intended to be chewed or dispersed. ## Pediatric Dosing Doses refer to **elemental iron**: - **Treatment of iron-deficiency anemia:** **3–6 mg/kg/day orally**, once daily or divided; use the lower end for mild disease and the higher end for severe anemia or selected high-risk situations. - **Prevention in term infants/children at risk:** Commonly **1–2 mg/kg/day**, according to age, diet, and local guidance. - **Preterm or low-birth-weight infants:** Often **2–4 mg/kg/day**, beginning when clinically appropriate; neonatal protocols should be followed. - A commonly used maximum for pediatric treatment is **200 mg elemental iron/day**, but product labeling and local pediatric protocols take precedence. - Do not exceed the prescribed dose. Accidental ingestion can cause life-threatening toxicity, particularly in young children. ## Dose Adjustments - **Renal impairment:** No routine dose adjustment is established for oral ferrous ascorbate. Treat the cause of anemia and consider functional iron deficiency, inflammation, or erythropoiesis-stimulating-agent protocols. - **Hepatic impairment:** No standard adjustment; avoid unnecessary iron in chronic liver disease or suspected iron overload. - **Malabsorption, ongoing blood loss, severe anemia, intolerance, or inadequate response:** Reassess diagnosis, adherence, bleeding, and absorption. Intravenous iron may be more appropriate under specialist guidance. - **Pregnancy:** Common prophylactic doses are approximately **30–60 mg elemental iron/day**; treatment dosing is generally **100–200 mg/day**, guided by obstetric and local protocols. - **Older adults:** No age-based adjustment, but investigate occult blood loss and alternative causes of anemia. ## Contraindications - Hypersensitivity to ferrous ascorbate or excipients. - Iron-overload disorders, including hemochromatosis or hemosiderosis, unless specifically directed by a specialist. - Anemias not caused by iron deficiency, including some hemolytic, sideroblastic, or thalassemia-related anemias. - Repeated transfusion-associated iron overload. - Use caution with active gastrointestinal ulceration, severe inflammatory bowel disease, or significant malabsorption. ## Adverse Effects Common, dose-related effects: - Nausea, abdominal discomfort, dyspepsia. - Constipation or diarrhea. - Vomiting. - Dark or black stools. - Metallic taste. - Heartburn. Other considerations: - Liquid preparations may stain teeth; administer toward the back of the mouth and rinse afterward. - Severe abdominal pain, persistent vomiting, lethargy, metabolic acidosis, or bloody diarrhea after ingestion may indicate acute iron poisoning and requires emergency treatment. - Iron can exacerbate gastrointestinal symptoms and may obscure assessment of gastrointestinal bleeding. ## Key Drug Interactions Separate oral iron from interacting medicines when clinically feasible: - **Levothyroxine:** Separate by at least **4 hours**; monitor thyroid function. - **Tetracyclines:** Separate by at least **2–4 hours**. - **Fluoroquinolones:** Separate by at least **2 hours before or 4–6 hours after** iron, depending on the antibiotic and local labeling. - **Bisphosphonates:** Separate by at least **2 hours**; follow the bisphosphonate-specific instructions. - **Antacids, calcium, magnesium, zinc, and other mineral supplements:** Separate by at least **2 hours**. - **Proton-pump inhibitors and chronic acid suppression:** May reduce iron absorption. - **Methyldopa:** Iron may reduce absorption and antihypertensive effect; separate administration and monitor blood pressure. - **Chloramphenicol:** May reduce hematologic response to iron. - **Penicillamine:** Separate by at least **2 hours**. - Food, especially calcium-containing foods, tea, coffee, and phytate-rich foods, can reduce absorption. ## Monitoring - Baseline and follow-up: CBC with hemoglobin, hematocrit, MCV, reticulocyte count when appropriate, ferritin, and transferrin saturation. - Recheck hemoglobin after approximately **2–4 weeks** in treated anemia. A rise of roughly **1–2 g/dL over 2–4 weeks** is generally expected if adherence, absorption, and diagnosis are appropriate. - Continue monitoring until hemoglobin normalizes and iron stores are replenished. - Investigate lack of response for nonadherence, incorrect dosing of elemental iron, ongoing blood loss, malabsorption, inflammation, or an alternative diagnosis. - Avoid routine iron therapy without monitoring in patients at risk for iron overload. - Monitor children closely for accidental ingestion. ## Clinical Pearls - Prescribe and document the dose as **mg of elemental iron**. - Ferrous ascorbate products are not interchangeable by tablet strength; confirm each product’s elemental iron equivalence. - Once-daily or alternate-day dosing may improve tolerability and may enhance absorption compared with frequent high-dose administration, although local protocols vary. - A response to iron does not replace evaluation for the cause of deficiency. In adults, assess for menstrual, gastrointestinal, dietary, surgical, or other blood loss as clinically appropriate. - Iron is absorbed best on an empty stomach, but taking it with a small amount of food is reasonable if gastrointestinal intolerance limits adherence. - Keep all iron products locked away from children. Any suspected overdose requires immediate poison-center or emergency evaluation; do not wait for symptoms. *Educational information only; verify the current product labeling, elemental-iron content, pediatric guidance, contraindications, and local prescribing protocol before use.*